Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056123PMC
http://dx.doi.org/10.1161/CIRCULATIONAHA.109.192704DOI Listing

Publication Analysis

Top Keywords

prevention torsade
4
torsade pointes
4
pointes hospital
4
hospital settings
4
settings scientific
4
scientific statement
4
statement american
4
american heart
4
heart association
4
association american
4

Similar Publications

Background: This case highlights the management of concomitant acute myocarditis and congenital long QT syndrome with electrical storm and incessant Torsade de Pointes.

Case Presentation: An 18 years-old Southeast Asian para 1 abortus 0 (P1A0) postpartum patient with cesarean section owing to severe preeclampsia, acute lymphocytic myocarditis, and prolonged QT interval owing to long QT syndrome. She has incessant Torsade de Pointes treated with beta-blocker, lidocaine, overdrive pacing with a temporary transvenous pacemaker, left cardiac sympathetic denervation per video-assisted thoracoscopic surgery, and implantable cardioverter-defibrillator implantation.

View Article and Find Full Text PDF
Article Synopsis
  • Drug-induced long QT syndrome (diLQTS) is a serious side effect of over 150 medications that can lead to dangerous heart conditions; the study aimed to validate a genetic risk score for predicting this syndrome.
  • Researchers analyzed data from a large cohort of patients taking high-risk QT-prolonging drugs and found that the risk score was significantly associated with diLQTS in White patients, indicating a higher likelihood of QT prolongation during treatment.
  • Although the risk score showed promise in identifying high-risk individuals, the study was underpowered to confirm its effectiveness across African American and Asian populations, highlighting the need for larger sample sizes in diverse groups.
View Article and Find Full Text PDF
Article Synopsis
  • This study investigated the link between anxiolytic drugs and the occurrence of Torsade de Pointes (TdP), a type of heart arrhythmia, using data from the FDA's Adverse Event Reporting System (FAERS) over a 30-year period.
  • Researchers identified 260 cases of TdP linked to anxiolytics and employed various data-mining algorithms to analyze the risk associated with these drugs.
  • The findings revealed six new signals of TdP risk linked to specific drugs, notably showing bromazepam and midazolam as the highest risk, while urging the need for more rigorous clinical studies to ensure patient safety.
View Article and Find Full Text PDF
Article Synopsis
  • * A case of a 25-year-old pregnant woman highlighted the importance of cardiac evaluation after foetal bradycardia was detected; she was diagnosed with LQTS type 1, and managed with medication and monitoring, resulting in a safe delivery.
  • * Early detection of foetal heart rate irregularities is critical in pregnancies, as persistent low heart rates can indicate LQTS and may require careful management strategies to ensure
View Article and Find Full Text PDF

Long QT syndrome (LQTS) is a severe cardiac disorder characterized by an abnormally prolonged QTc interval on an electrocardiogram (ECG), which can result in life-threatening irregular heart rhythms. The use of certain medications, particularly anti-arrhythmic drugs such as quinidine, sotalol, and amiodarone, can lead to acquired LQTS by prolonging the QT interval through the inhibition of specific ion channels responsible for heart repolarization, which may present symptoms like fainting, seizures, and sudden cardiac arrest. This systematic review, conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, focused on analyzing the association between Long QT syndrome and drugs utilized for managing arrhythmias, involving a thorough examination of six selected studies from an initial pool of 68 articles.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!